Search the web
Sign In
New User? Sign Up
Gleevec
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Show off your group to the world. Share a photo of your group with us.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
Most Read Articles on Cancer   Message List  
Reply | Forward Message #4795 of 4801 |



Most read Oncology news in the past 7 days

Papers and articles, pertaining to Oncology, most read by your
colleagues in the past 7 days


Cetuximab and irinotecan as third-line therapy in advanced colorectal
cancer patients: a single centre phase II trial (Br J Cancer)
Docetaxel and gemcitabine combination in 133 advanced soft-tissue
sarcomas: A retrospective analysis (Int J Cancer)
Angiogenesis modifications related with cetuximab plus irinotecan as
anticancer treatment in advanced colorectal cancer patients (Ann
Oncol)
Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in
combination with gemcitabine and carboplatin in patients with
advanced non-small cell lung cancer (Lung Cancer Online)
Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant
metastatic pancreatic cancer (Br J Cancer)
Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium
folinate in metastatic gastrointestinal cancer patients: original
analysis of non-hematological toxicity and patient characteristics in
a pilot investigation (Int J Clin Pharmacol ther)
Glucocorticoids interfere with therapeutic efficacy of paclitaxel
against human breast and ovarian xenograft tumors (Int J Cancer)
Irinotecan/5-fluorouracil combination induces alterations in
mitochondrial membrane potential and caspases on colon cancer cell
lines (Oncol Res)
A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in
patients aged 60 plus with aggressive non-Hodgkin's lymphoma (Br J
Cancer)
Optimizing the use of aromatase inhibitors in adjuvant therapy for
postmenopausal patients with hormone-responsive early breast cancer:
current and future prospects (J Cancer Res Clin Oncol)
More news...








Thu Mar 9, 2006 4:30 pm

telephonics
Offline Offline
Send Email Send Email

Forward
Message #4795 of 4801 |
Expand Messages Author Sort by Date

Most read Oncology news in the past 7 days Papers and articles, pertaining to Oncology, most read by your colleagues in the past 7 days Cetuximab and...
telephonics
Offline Send Email
Mar 9, 2006
4:30 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help